
A non-invasive treatment, that has been tested on in the UK, may provide the much - required relief to Type 1 diabetes patients who need a daily jab.
The treatment, an insulin pump, works by mimicking the body's pancreas delivering measured doses of insulin through the layer of tissue just beneath the skin.
Advertisement
It completely rules out the use of injections.
The results have impressed the patients who reportedly admitted an improved quality of life.
A consultant at the Royal Cornwall Hospital in Truro, Dr Duncan Brown, also revealed that the insulin pump could also prevent hypoglycaemic attacks.
He said that the 'unpredictable attacks' of diabetes can hamper the routine life of patients and the pump can reverse it for them.
"For some patients with Type 1 this can be very disabling," the BBC quoted him, as saying.
"It can cause them to lose consciousness at unpredictable times, meaning they cannot drive.
"The pump can reverse this, meaning they have a better quality of life and can get back to doing normal things like driving."
Source: ANI
MAR/P
A consultant at the Royal Cornwall Hospital in Truro, Dr Duncan Brown, also revealed that the insulin pump could also prevent hypoglycaemic attacks.
Advertisement
He said that the 'unpredictable attacks' of diabetes can hamper the routine life of patients and the pump can reverse it for them.
"For some patients with Type 1 this can be very disabling," the BBC quoted him, as saying.
"It can cause them to lose consciousness at unpredictable times, meaning they cannot drive.
"The pump can reverse this, meaning they have a better quality of life and can get back to doing normal things like driving."
Source: ANI
MAR/P
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Diabetes News

Physical activity or exercise in the morning and afternoon reduces type 2 diabetes risk, whereas evening exercise has no such association.

Late sleepers and late risers may both have a higher risk of developing diabetes.

Semaglutide, the anti-diabetic drug operating by stimulating insulin secretion, might have the potential to supplant the need for mealtime insulin injections.

The gut bacteria known as Lachnospiraceae might have the ability to boost insulin sensitivity, potentially providing a protective barrier against diabetes.

Type 2 diabetes-led cardiovascular risk needs mandatory interdisciplinary, patient-centered care to reduce morbidity and mortality.